Research publications

'Publication' is the term used when the results of research carried out by scientists are made public knowledge. These publications are seen worldwide in journals and on the internet.

For publications to be accepted by a journal, they have to be reviewed by a panel of experts. Publications are a very important way for researchers to share their findings with the scientific community - driving breast cancer research forward.

Campaign's Scientific Advisory Board will look at publications of scientists applying for the charity's grants as an indication of how well they are progressing in their chosen field of research.

Below is a list of publications that have resulted from the ongoing and completed research projects that have been funded by Breast Cancer Campaign. If you would like to know something more specific, please email research@breastcancercampaign.org

31/12/2005 Journal of Biological Chemistry. J. Mamm. Gland Biol. Neoplasia, 10, 1, 1-3.	Stem Cells and Tissue Homeostasis in Mammary Glands
01/03/2002 Journal of Pathology. 196:254-265	The role of tumour associated macrophages in tumour progression: implications for new anticancer therapies
31/12/2001 Oncogene. 20:6123-6131	BRCA1 and GADD45 mediated G2/M cell cycle arrest in response to antimicrotubule agents
31/12/2001 In press. Clinical Cancer Research 7:2555-2562	A hammerhead ribozyme suppresses expression of hepatocyte growth factor/scatter factor receptor c-MET and reduces migration and invasiveness of breast cancer cells
31/12/2001 International Journal of Oncology. 19:857-863	Expression of hepatpcyte growth factor/scatter factor, its activator, inhibitors and the c-Met receptor in human cancer
01/01/2001 Cytopathology. 12:1-3	Cellular characteristics of nipple aspiration fluid during the menstrual cycle in health premenopausal women
01/02/2002 The Lancet	BRCA1- Mechanism of inactivation and implications for patient management
01/01/2002 Proceedings of the National Academy of.Science USA. 99,6806-6811	BORIS, a novel male germline-specific protein associated with epigenetic reprogramming events, shares the same 11 Zn-finger domain with CTCF, the insulator protein involved in reading imprinting marks in the soma
01/01/2002 Molecular Genetics. 11:1433-1438	A potential role for the XRCC2 R188H polymorphic site in DNA-damage repair and breast cancer
01/01/2001 Oncogene, 20:1509-1518	Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumors
01/01/2001 Journal of Clinical Pathology: Molecular Pathology, 2001. 54:300-306	Chromosome 3p allele loss in early invasive breast cancer: detailedmapping and association with clinical-pathological features
01/01/2000 Journal of Molecular Diagnostics (American Journal of Pathology part B). 2:139-144	Improving the detection of p53 mutations in breast cancer by use of the FASAY, a functional assay
01/01/1999 Journal of Cell Science 112:3943-3954	The intracellular hyaluronan receptor RHAMM/IHABO interacts with microtubles and actin filaments
01/01/1998 Journal of Cell Science 11:1685-1694	The human hyaluronana receptor RHAMM is expressed as an intracellular protein in breast cancer cells
01/01/2001 International Journal of Cancer. 92:404-408	Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast
30/12/2003 British Journal of Radiology. 76:561-563	Breast density: agreement of measures from film and digital image.
01/05/2003 Scottish Medical Journal	P-glycoprotein over-expression indicates resistance to docetaxel in human breast cancer cells.
01/01/2002 Cytometry In press	Cell filtration-laser scanning cytometry for the characterisation of circulating breast cancer cells.
01/01/2003 Human Molecular Genetics. 12: 915-923	A naturally occuring mutation in an ATP-binding domain of the recombination repair gene XRCC3 ablates its function without causing cancer susceptibility
01/01/2002 British Journal of Cancer. 87,834-839	BAG-1 expression and function in human cancer.
01/01/2003 Biochimica et Biophysica Acta (Reviews on Cancer) 1603: 83-98	BAG-1: A Multifunctional regulator of cell growth and survival.
01/01/2003 Oncogene	The Nuclear BAG-1 isoform BAG-1L enhances oestrogen-dependent transcription.
01/01/2003 Cancer Research	BAG-1 prevents stress-induced long term growth inhibition in breast cancer cells via a chaperone dependent pathway.
01/08/2003 Journal of Pathology. 200:53-58	The title of E-cadherin in low-grade ductal breast tumourigenesis.
01/12/2002 Tumor Biology. 23: 263-314	Prostate specific antigen (PSA) in nipple aspiration fluid (NAF): menstrual cycle variability and correlation with serum PSA.
01/12/2002 British Journal of Cancer. 86:1373-1378.	Womens� Knowledge and beliefs regarding breast cancer
01/08/2003 Journal of Psychosomatic Research. 54:141-146.	Perceptions of breast cancer across the lifespan.
01/12/2002 Cell Signal 14, 381-395.	The protein kinase B/Akt signalling pathway in human malignancy.
01/12/2002 of Cell Science 115, 3404-3414.	Farnesylation of Cenp-F is required for G2/M progression and degradation after mitosis.
01/01/2001 Clinical Cancer Research. 7: 2555-2562	Supression of invasiveness and cellular motility of breast cancer cells by a hammerhead ribozyme encoding cMET antisense. ribozyme encoding cMET antisense.
01/01/2002 International Journal of Cancer. 101: 555-559	Survival in prospectively ascertained familial breast cancer: analysis of a series stratified by tumour characteristics, BRCA muatations and oophorectomy.
01/08/2003 British Journal of Cancer. 88:1256-1262.	The Scottish/Northern Irish BRCA1/BRCA2 Consortium. BRCA1 and BRCA2 mutations in Scotland and Northern Ireland.
01/01/2004 British Journal of Cancer. 91: 2071-2078	Epigenetic inactivation of SLIT3 and SLIT1 genes in human cancers
01/01/2004 Journal of the National Cancer Institute. 96: 1659-1668	The role of of BRCA1 in the cellular response to chemotherapy
01/01/2004 Journal of the National Cancer Institute. 96: 1659-1668	The role of of BRCA1 in the cellular response to chemotherapy
01/01/2004 Journal of the National Cancer Institute. 96: 1866-1869	Association of a common variant of the CASP8 gene with reduced risk of breast cancer
01/01/2002 Arthritis and Rheumatism 46 (4): 961-967	The modulation of Matrix Metalloproteinase and ADAM Gene Expression in Human Chondrocytes by Interleukin-1 and Oncostatin M
01/01/2003 Arthritis and Rheumatism 50 (1):131-141	Expression profiling of metalloproteinases and their inhibitors in cartilage
01/01/2004 Clinical Cancer Research 10: 2429-2440	Dysregulated Expression of Adamalysin-Thrombospondin Genes in Human Breast Carcinoma
01/01/2003 International Journal of Cancer 106:364-71	The retinoblastoma protein interacts with BAG-1 in human colonic adenoma and carcinoma derived cell lines.
01/01/2004 Expert Reviews in Molecular Medicine 1-15	BAG-1 in carcinogenesis
01/01/2005 International Journal of Biochemistry and Cell Biology 37 (2):251-259	BAG-1: A multifunctional pro-survival molecule
01/01/2005 Clinical Oncology 2005 17: 16-24	Reduction of radiotherapy-induced late complications in breast cancer: the role of intensity modulated radiation therapy (IMRT) and partial breast irradiation. Part i- Normal tissue complications.
01/01/2005 Clinical Oncology 2005 17: 98-110	Reduction of radiotherapy-induced late complications in breast cancer: the role of intensity modulated radiation therapy (IMRT) and partial breast irradiation. Part II- Radiotherapy strategies to reduce radiation induced late effects
01/02/2004 Journal of Mammary Gland Biology and Neoplasia 9, 119-31	Wnt proteins in Mammary Development and Cancer
01/02/2004 Journal of Mammary Gland Biology and Neoplasia 9, 119-31	Wnt proteins in Mammary Development and Cancer
01/01/2005 International Journal of Cancer 113 (3): 364-371	Sequence- and schedule-dependent enhancement of zoledronic acid induced apoptosis by doxorubicin in breast and prostate cancer cells.
01/01/2005 International Journal of Cancer 113 (3): 364-371	Sequence- and schedule-dependent enhancement of zoledronic acid induced apoptosis by doxorubicin in breast and prostate cancer cells.
01/01/2005 Journal of Anticancer Drugs 16 (1): 11-19	Preclinical evidence for the effect of bisphosphonates and cytotoxic drugs on tumour cell invasion.
01/01/2005 Journal of Anticancer Drugs 16 (1): 11-19	Preclinical evidence for the effect of bisphosphonates and cytotoxic drugs on tumour cell invasion.
01/01/2004 Mutation Detection edited by Graham Taylor and Ian Day Wiley	MeltMADGE: economical very high throughout mutation screening using thermal ramp electrophoresis in conjunction with MADGE (microplate array) gels
01/01/2003 British Journal of Cancer 88 (Suppl 1) : S59	Characterisation of docetaxal resistance in breast cancer cell lines
01/01/2003 British Jounral of Cancer 88 (Suppl 1): S59	Bcl-2 expression in a docetaxal resistant breast cancer cell line
27/12/2005 Apoptosis 10:301-311	Nuclear BAG-1 expression inhibits apoptosis in colorectal adenoma derived epithelial cells: Implications in colorectal tumour development.
14/03/2006 International Journal of Cancer 118, 1241 -1247	ADAMTS8 and ADAMTS15 predict survival in human breast carcinoma
01/01/2003 European Journal of Surgical Oncology 29:824	A novel mechanism of HER2 is not involved in resistance to docetaxal in breast cancer cell lines
01/01/2003 European Journal of Surgical Oncology 29: 820-821	Amplification of HER2 is not involved in resistance to docetaxal in breast cancer cell lines
01/01/2003 European Journal of Cancer 1:16	Detection of a common amplification of 7q in docetaxal resistant breast cancer cell lines by comparative genomic hybridization
01/01/2003 European Journal of Cancer: 1: 16-17	Molecular changes involved in docetaxal resistance in breast cancer cell lines
01/01/2003 Scottish Medical Journal 48:130	Comparative genomic changes associated with docetaxal resistance in breast cancer cell lines
01/01/2003 Scottish Medical Journal 48:127	Molecular changes associated with docetaxal resistance in breast cancer cell using cDNA microarray analyses
01/01/2004	Identification of the molecular mechanisms of docetaxal resistance in breast cancer cells
01/01/2004 Breast Cancer Research and Treatment 6 (5): R601-607	Reduced expression of p27 is a novel mechanism of docetaxal resistance in breast cancer cells
01/01/2003 Cancer Research 63: 6221-6228	BRCA1 functions as a differential modulator of chemotherapy induced apoptosis
01/01/2003 Journal of Cell Science 116: 4557-4566	Tetraspanin CD82 regulates compartmentalisation and ligand-induced dimerization of EGFR
01/01/2005 Cancer Research 65: 2690-2697	Transcriptional Regulation of Cyclin A2 by RASSF1A through the Enhanced Binding of p120E4F to the Cyclin A2 Promoter
01/01/2004 Journal of Cancer Research 64:1002-107	Identification of the E1A-regulated transcription factor p120E4F as an interacting partner of the RASSF1A candidate tumor suppressor gene
01/01/2004 Journal Cancer Research 64 (12): 4112-4116	RASSF1A Interacts with Microtubule-Associated Proteins and Modulates Microtubule Dynamics
01/01/2004 Journal Cancer Research 64: 102-107	Identification of the E1A-regulated transcription factor p120E4F as an interacting partner of the RASSF1A candidate tumor suppressor gene
01/01/2004 Cancer Casues and Controls 15 (9):947-955	Life course breast cancer risk factors and adult breast density
01/01/2003 Diagnostic Molecular Pathology 12:27-34	Molecular Classification of Breast Carcinomas Using Tissue Microarrays
01/01/2002 Seminars in Cancer Biology 12:399-414	The novel BORIS+CTCF gene family is uniquely involved in the epigenetics of normal biology and cancer
01/01/2004 Lancet Oncology 5:174-181	Oestrogen receptor b: What does this mean to the breast cancer patient?
01/01/2003 Biochemical Pharmacology 66: 1563-1569	Turning cell cycle controller genes into cancer drugs. A role for antiproliferative cytokine
01/01/2005 Cancer Research 65: 1631-1634	Circumventing multi-drug resistance in cancer by bGBP, an anti-proliferative cytokine
01/01/1999	Nipple aspiration fluid (NAF). The new mammography?
01/01/2002 Breast Cancer Re. Tret. 76 (suppl 11):216	Cell filtration: a simple method to isolate putative cancer cells from the blood of patients with metastatic breast cancer.
01/01/2005 British Journal of Cancer 92: 906-912	Detection of circulating epithelial cells in the blood of patients with breast cancer: comparison of laser scanning cytomology following cell filtration or immunomagnetic separation with a multiple marker real time RT-PCR assay
01/02/2004 Journal of Mammary Gland Biology and Neoplasia 9, 119-31	Wnt proteins in Mammary Development and Cancer
01/01/2005 Journal of Protein Expression and Purification	Identification and purification of a soluble region in the breast cancer susceptibility protein BRCA2
01/01/2005 Cancer Research 65 (8): 3072-3080	Expression of the Brn-3b transcription factor correlates with expression of HSP27 in breast cancer biopsies and is required for maximal activation of the HSP27 promoter
01/01/2005 European Journal of Cancer � 41 (07): 1086-1094	Genomic changes identified by comparative genomic hybridisation in docetaxel resistant breast cancer cell lines.
01/01/2003 Journal of Cellular Physiology, in press	Biphasic effects of 17-b-estradiol on expression of occluding and transendothelial resistance and paracellular permeability in human vascular endothelial cells.
01/01/2003 International Journal of Cancer in press	Expression of peroxisome-proliferator activated receptor-gamma (PPARg) and the PPARg co-activator, PGC-1, in human breast cancer correlates with clinical outcomes.
01/01/2003 Carcinogenesis, in press	Growth and angiogenesis of human breast cancer in a nude mouse tumour model is reduced by NK4, the HGF/SF antagonist.
01/01/2002 Journal of Cellular Physiology. 192:268-275.	Antagonistic effect of NK4 on HGF/SF induced changes in the transendothelial resistance (TER) and paracellular permeability of human vascular endothelial cells.
01/01/2002 Critical Reviews in Oncology/Hematology. 43:13-31.	Molecular detection of micro-metastasis in breast cancer.
01/01/2005 Cancer Research 65: 3497-3508.	Role Of The Ras Association Domain Family 1 (Rassf1) Tumor Suppressor Gene In Human Cancers.
01/01/2005 Molecular Cell 18: 637-650	The Tumor Suppressor, RASSF1A and MAP-1 Link Death Receptor Signaling to Bax Conformational Change and Cell Death.
20/11/2004 European Biophysics journal	Interaction of Metastasis-inducing S100A4 Protein in vivo by Fluorescence Lifetime Imaging Microscopy.
21/12/2004 Clinical Cancer Research 10: 5472-5481	Vitamin D receptor gene polymorphisms and breast cancer risk.
27/12/2004 Biochemical Journal	Heterodimimeric interaction and interfaces of S100A1 and S100P
27/12/2005 Onogene 24 (27) 4401-11	The c-terminal region of S100A4 is important for it's metastasis-inducing properties
27/02/2003 BREAST CANCER RESEARCH AND TREATMENT 81(2):117-128	Autocrine signalling through erbB receptors promotes constitutive activation of protein kinase B/Akt in breast cancer cell lines
27/02/2001 Journal of Cell Science. 114, 4382-4395)	Kinetochore localisation localisation and phosphorylation of the mitotic cheakcpoint components Bub1 and BubR1 are differentially regulated by spindle events in human cells
27/11/2005 Endocrine-Related Cancer 12: 1017�1036	The anti-oestrogen ICI 182,780, but not tamoxifen, inhibits the growth of MCF-7 breast cancer cells refractory to long-term oestrogen deprivation through down-regulation of oestrogen receptor and IGF signalling
27/12/2005 European Journal of Cancer	Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population
27/02/2003 Anti-Cancer Drugs 13 (5):11	Approaches to evaluating the association of vitamin D receptor gene polymorphisms with breast cancer risk.
27/02/2006 British Journal of Cancer 94, 101 � 107	Macrophages promote angiogenesis in human breast tumour spheroids in vivo
27/02/2006 British Jounal of Cancer 94(1) 101-107	Role of macrophages in breast tumour angiogenesis in vivo
28/02/2002 British Journal of Cancer 86:Suppl.1, 85.	A new approach to breast cancer control. Turning cell cycle controller genes into cancer drugs.
27/12/2005 Current Opinion in Investigational Drugs 6(12): 1228-33	Potential role of the antiproliferative cytokine ?-galactoside binding protein in cancer therapy
27/12/2005 Cancer Research 65 (12) 5112-5122	Heightened expression of CTCF in breast cancer cells is associated with resistance to apoptosis.
27/12/2005 Journal of Biological Chemistry 280 (30): 28152-28161	CTCF regulates growth and erythroid differentiation of human myeloid leukemia cells.
27/02/2002 Cancer Research	BORIS, a cancer-testis gene that shares an 11 zinc finger DNA-binding domain with the tumor suppressor gene CTCF, is aberrantly expressed in multiple myeloma.
27/12/2005 Cell Cycle 4, 96-101.	Poly(ADP-ribosyl)ation and epigenetics: Is CTCF PARt of the plot?
27/12/2005 FEBS Letters 579, 6, 1424-1434	Regulation of the transcription factor, CTCF, by phosphorylation with protein kinase CK2
14/03/2006 Apoptosis	C-terminal binding proteins: emerging roles in cell survival and tumorigenesis
14/03/2006 Apoptosis	C-terminal binding proteins: emerging roles in cell survival and tumorigenesis
22/03/2006 Br J Health Psychol. 8(Pt 3):319-33	Help-seeking intentions for breast-cancer symptoms: a comparison of the self-regulation model and the theory of planned behaviour.
21/12/2005 Recent Results in Cancer Research 164: 43-54	Approaches to evaluating the association of vitamin D receptor gene polymorphisms with breast cancer risk.
21/02/2004 British Journal of Cancer Suppl. 191 S24 (2004)	The effects of a novel CDK inhibitor on tamoxifen sensitive and resistant breast cancer cell lines
21/02/2006 British Journal of Cancer 91: Suppl. 1: S9 1.6.	Improving breast cancer treatment using novel poly(ADP-ribose) polymerase (PARP-1) inhibitors
21/11/2004 Current Trends in Genetics 5	Paucimorphic alleles versus polymorphic alleles in disease causation: theory, observation and detection.
21/02/2004 British Journal of Pharmacology	GW9662, a potent antagonist of PPARgamma , inhibits growth of breast tumour cells and promotes the anticancer effects pf the PPARgamma agonist rosiglitazone, independently of PPARgamma activation
21/02/2003 British Journal of Cancer 89: 1834-1836	Experiences of men with breast cancer: an exploratory focus group study
21/02/2003 Biochemical Society Transitions 31:257-62.	Role played by BRCA1 in regulating the cellular response to stress
21/02/2003 Cancer 98 (6): 1327-1328	The biology of breast carcinoma
21/02/2003 Journal of Cellular Physiology 196:362-369	Biphasic effects of 17-b-estradiol on expression of occluding and transendothelial resistance and paracellular permeability in human vascular endothelial cells
21/02/2003 Carcinogenesis 24:1317-1323	Growth and angiogenesis of human breast cancer in a nude mouse tumour model is reduced by NK4, the HGF/SF antagonist
21/02/2002 Critical Reviews in Oncology Hematology 43:13-31	Molecular detection of micro-metastasis in breast cancer
21/02/2002 Journal of Cellular Physiology 192:268-275.	Antagonistic effect of NK4 on HGF/SF induced changes in the transendothelial resistance (TER) and paracellular permeability of human vascular endothelial cells
21/02/2004 Clinical Cancer Research 10: 202-211	The hepatocyte growth factor regulatory factors in human breast cancer
21/02/2004 Clinical and Experimental Metastasis. 21:31-37	Expression of tumour-endothelial markers in human breast cancer.
21/02/2004 European Journal of Cancer 40:494-502	Aberrant expression of interleukin-7 (IL-7) and its signalling complex in human breast cancer
21/02/2004 Breast Cancer Research	Activated leukocyte cell adhesion molecule in breast cancer
21/02/2004 International Journal of Oncology 25: 81-85	Psoriasin is aberrantly expressed in human breast cancer and is related to clinical outco
21/12/2005 Nature Genetics	Poly(ADP-ribosyl)ation regulates CTCF-dependent chromatin insulation.
21/02/2004 Nature Structural & Molecular Biology	CTCF interacts with the largest subunit of RNA Polymerase II constitutively in vitro and in a sequence-specific context in vivo: Implications for the mechanism of the chromatin insulator function and the origin of intergenic, non-coding transcripts
21/01/2004 Journal of Neuoscience 24: 5966-5973	YB-1 and CTCF differentially regulate the 5-HTT polymorphic intron 2 enhancer which predisposes to a variety of neurological disorders.
21/02/2004 Cell 117:337-347	Telomere maintenance requires the RAD51D recombination/repair protein
20/02/2004 Journal of Medical Genetics 41 (7): 523-528	Heterozygote excess is repeatedly observed in females at the BRCA2 locus N372H
27/02/2006 Journal of Clinical Oncology 24 (1)	Psychological distress in men with breast cancer
27/02/2006 European Journal of Cancer 42(3)	The Experiences of Men with Breast Cancer in the United Kingdom
27/02/2003 BMJ	Breast Cancer in Men
27/12/2005 Journal of Pathology 205 (3): 388-396	Identification and validation of prognostic markers in breast cancer with the complementary use of array-CGH and tissue microarrays
27/02/2004 Proc. Amm. Assoc. Cancer Res. 45 825 (2004)	The use of novel CDK inhibitors in the treatment of hormone refractory breast cancer
27/02/2005 Breast Cancer Res Treat 92: 287-293	A multi-centre investigation towards reaching a consensus on the immunohistochemical detection of Erb in archival formalin-fixed paraffin embedded human breast tissue
27/12/2005 Eur J Surg Oncol 31: 1073	Modulation of p27 expression can alter docetaxel-induced cytotoxicity in breast cancer cells
27/12/2005 Eur J Surg Oncol 31: 1059	Identification of minimal regions of genomic alteration associated with docetaxel resistance in breast cancer cells
27/02/2006	The significance of the CtBP: AdE1A interaction during viral infection and transformation
27/02/2006	The significance of the CtBP: AdE1A interaction during viral infection and transformation
27/12/2005 Biochemical Journal 386(1) 15-27	The ADAMTS metalloproteinases
27/02/2003 Oncology Reports 10:2039-2044	Expression of transglutaminases and the clinical significance in human breast cancer.
27/02/2003 Breast Cancer Research and Treatment 76 (Suppl 1), S165	Hepatocyte growth factor activators (HGFA and matriptase-1) and HGF inhibitors in human breast cancer
27/12/2005	Tuberin And Hamartin Are Aberrantly Expressed And Linked To Clinical Outcome In Human Breast Cancer, The Role Of Promoter Methylation Of Tsc Genes
27/12/2005 International Journal of Cancer 117 (5): 730-737	Expression of Com-1/p8 in human breast cancer, and its relevance to clinical outcome and ER status
27/12/2005 Critical Review in Oncology and Hematology 53 (1), 35-69	Hepatocyte growth factor, its receptor, and their potential value in cancer therapies
27/12/2005 The Breast 14 (5): 360-367	The Elevated Level Of Cxcr4 Is Correlated With Nodal Metastasis Of Human Breast Cancer
27/02/2006 Radiotherapy & Oncology 73; 1: S15.	Implementation of breast IMRT via a randomised controlled trial: a report of the first year's experience
27/02/2004 Breast Cancer Research and Treatment 86;269-279	Osteoprotegerin (OPG) produced by bone marrow stromal cells protects breast cancer cells from TRAIL-induced apoptosis
27/02/2004 Breast Cancer Research and Treatment 86;269-279	Osteoprotegerin (OPG) produced by bone marrow stromal cells protects breast cancer cells from TRAIL-induced apoptosis
27/12/2005 Int J Cancer	Osteoprotegerin (OPG) - a potential new role in the regulation of endothelial cell phenotype and tumour angiogenesis?
27/12/2005 Int J Cancer	Osteoprotegerin (OPG) - a potential new role in the regulation of endothelial cell phenotype and tumour angiogenesis?
27/12/2005 Tumor Biology	Mechanisms of the synergistic interaction between the bisphosphonate Zoledronic Acid and the chemotherapy agents Paclitaxel in breast cancer cells in vitro
27/12/2005 Tumor Biology	Mechanisms of the synergistic interaction between the bisphosphonate Zoledronic Acid and the chemotherapy agents Paclitaxel in breast cancer cells in vitro
27/12/2005	The Combined Effects of Zoledronic Acid and Doxorubicin on Breast Cancer Cell Invasion In vitro Anticancer Drugs
27/12/2005	The Combined Effects of Zoledronic Acid and Doxorubicin on Breast Cancer Cell Invasion In vitro Anticancer Drugs
27/12/2005 Breast Cancer Research and Treatment 92:207-215	Osteoprotegerin (OPG) expression by breast cancer cells in vitro and breast tumours in vivo - a role in tumour cell survival?
27/12/2005 Breast Cancer Research and Treatment 92:207-215	Osteoprotegerin (OPG) expression by breast cancer cells in vitro and breast tumours in vivo - a role in tumour cell survival?
27/12/2005 Palliative Medicine 17: 539-553	The use of zoledronic acid in the management of metastatic bone disease and hypercalcaemia
27/12/2005 Palliative Medicine 17: 539-553	The use of zoledronic acid in the management of metastatic bone disease and hypercalcaemia
27/02/2004 Endocrine Related Cancer 11(2): 207-24	The role of bisphosphonates in breast and prostate cancers
27/02/2004 Endocrine Related Cancer 11(2): 207-24	The role of bisphosphonates in breast and prostate cancers
27/02/2004 Journal of Clinical Oncology	Quantification of regulatory T-cells enables the identification of high-risk breast cancer patients
27/02/2004 Journal of Clinical Oncology	Quantification of regulatory T-cells enables the identification of high-risk breast cancer patients
27/12/2005 Nature 434, 598-604	CDK-dependent phosphorylation of BRCA2 as a regulatory mechanism for recombinational repair
27/12/2005 Proc Natl Acad Sci U S A 102, 8537-8542	BRCA2 BRC motifs bind RAD51-DNA filaments
27/12/2005 Cancer Research	Aberrant
27/12/2005 Cancer Research 64, 6840-4	A recurrent chromosome breakpoint in breast cancer at the NRG1/neuregulin 1/heregulin gene.
27/12/2005 Cancer Research 64, 6840-4	A recurrent chromosome breakpoint in breast cancer at the NRG1/neuregulin 1/heregulin gene.
27/12/2005 Endocrine related cancer 12: S17-S27 Suppl. 1	The Epidermal Growth Factor Receptor Family
27/12/2005 Endocrine related cancer 12: S17-S27 Suppl. 1	The Epidermal Growth Factor Receptor Family
27/12/2004 British Journal of Cancer. 91(5): 817-21.	Targeting cytotoxic T-cells for cancer immunotherapy
27/12/2004 British Journal of Cancer. 91(5): 817-21.	Targeting cytotoxic T-cells for cancer immunotherapy
27/12/2005 EMBO Journal	Distinct modes of ATR activation after replication stress and DNA double strand breaks in C. elegans
27/12/2005 EMBO Journal	Distinct modes of ATR activation after replication stress and DNA double strand breaks in C. elegans
27/02/2006 Dalton Transactions	Synthesis, Structure and Assessment of the Cytotoxic Properties of 2,5-Dimethylazaferrocenyl Phosphonates
27/02/2006 Dalton Transactions	Synthesis, Structure and Assessment of the Cytotoxic Properties of 2,5-Dimethylazaferrocenyl Phosphonates
27/12/2005 Nature 434: March 598- 604	CDK-dependent phosphorlation of BRCA2 as a regulatory mechanism for recombinational repair
27/12/2005 Nature 434: March 598- 604	CDK-dependent phosphorlation of BRCA2 as a regulatory mechanism for recombinational repair
27/12/2005 Biophysics 102 (24) 8537-8542	BRCA2 BRC motifs bind RAD51-DNA filaments
27/12/2005 Biophysics 102 (24) 8537-8542	BRCA2 BRC motifs bind RAD51-DNA filaments
09/03/2006 Cancer Research 66: 1517-1525	Aberrant Activation of Notch Signaling in Human Breast Cancer
09/03/2006 Cancer Research 66: 1517-1525	Aberrant Activation of Notch Signaling in Human Breast Cancer
10/03/2004 Cancer Reseach 64 (12): 4148-4154	BRCA1 interacts with and is required for paclitaxel-induced activation of mitogen-activated protein kinase kinase kinase 3
10/12/2005 Biochemical pharmacology 71 13-20.	Sensitization of breast carcinoma cells to ionizing radiation by small molecule inhibitors of DNA-dependent protein kinase and ataxia telangiectsia mutated
10/12/2005 Biochemical pharmacology 71 13-20.	Sensitization of breast carcinoma cells to ionizing radiation by small molecule inhibitors of DNA-dependent protein kinase and ataxia telangiectsia mutated
10/12/2005 Molecular Cell 20, 783-792	Human DNA Polymerase n Promotes DNA sSynthesis from Strand Invasion Intermediates of Homologous Recombination
14/03/2006 Genome Research 15:967�977	Mutation scanning by meltMADGE: Validations using BRCA1 and LDLR, and demonstration of the potential to identify severe, moderate, silent, rare, and paucimorphic mutations in the general population
14/12/2005 Clinical Cancer Research 11 (16), 6012-6019	Targeting matrilysin and its impact on tumour growth in vivo, the potential implications in breast cancer therapy
14/12/2005 International Journal of Molecular Medicine 16(4):723-8	The potential lymphangiogenic effects of hepatocyte growth factor/scatter factor in vitro and in vivo
14/03/2006 Journal of Histochemistry and Cytochemistry 54(2):231-41	Expression of Autocrine Motility Factor (AMF) and its receptor, AMFR, in human breast cancer
14/03/2006 BMC Cancer 23;6:16.	Angiomotin and angiomotin like proteins, their expression and correlation with angiogenesis and clinical outcome in human breast cancer
14/03/2006 The Breast 14(5):360-7	The elevated level of CXCR4 expression is correlated with lymph node metastasis in human breast cancer
14/03/2006 Breast Cancer Research 7, R402-R410	Stroma-derived factor 1 (SDF-1) and the invasiveness of breast cancer cells, the clinical implications
14/03/2006 Breast Cancer Research R478-487	Prognostic value of ALCAM in human breast cancer
14/03/2006 European Journal of Cancer 41(18):2819-27	Placenta growth factor is over-expressed and has prognostic value in human breast cancer.


or search by keyword